J&J has received the US FDA approval for Rybrevant Faspro, a SC administered therapy to treat patients with EGFR-mutated ...
Biomarker Therapy in 2025: More Lung Cancer Options, Competition in New Drug Classes, ctDNA Advances
This year, there was a surge of new lung cancer treatments, more options for patients with earlier-stage disease, and growing ...
In a study published in The Journal of Clinical Investigation, University of Michigan researchers found a new protein target ...
Lung development begins during embryogenesis and continues after birth. It includes branching of airways, formation of ...
Long after their active duty ends, many veterans in North San Diego County, California, continue to shoulder the health risks ...
What will be the next blockbuster research to emerge from Princeton’s labs? No one can say for sure, but history tells us ...
Genmab (Otc) ($GMAB) announced an update on their ongoing clinical study. Genmab has announced a new Phase 2 clinical study designed to evaluate ...
A multidisciplinary team integrated clinical need, cancer biology, and microfluidic bioengineering to advance ...
Researchers demonstrate breakthroughs in cancer treatment quality through AI-enhanced data analytics
Cancer researchers at the University of Tennessee Health Science Center have published three new studies demonstrating how ...
Cancer-diagnosing AI models can secretly read patient demographics from pathology slides, leading to biased results.
Analyzing several major pathology AI models designed to diagnose cancer, the researchers found unequal performance in ...
While most women over age 50 schedule mammograms for breast cancer, only a minority who are also eligible for low-dose CT scans for lung cancer undergo those potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results